MedTrace Logo

Patient Reported Outcomes Following Targeted Muscle Reinnervation

NCT04658368 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 2

Last updated 2025-11-05

No results posted yet for this study

Summary

The purpose of this study is to characterize the functional status and quality of life of patients undergoing Targeted Muscle Reinnervation (TMR) at time of major limb amputation (primary) or subsequent to major limb amputation (secondary). Participants can expect to be on study for about a year and will complete a short electronic survey and option phone interview.

Conditions

  • Amputation

Interventions

PROCEDURE

Primary TMR

TMR procedure as part of the primary major limb amputation surgery

PROCEDURE

Secondary TMR

TMR procedure subsequent to major limb amputation surgery

Sponsors & Collaborators

  • University of Wisconsin, Madison

    lead OTHER

Principal Investigators

  • Brett F Michelotti, MD · University of Wisconsin, Madison

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-29
Primary Completion
2022-09-01
Completion
2022-09-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04658368 on ClinicalTrials.gov